<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02629380</url>
  </required_header>
  <id_info>
    <org_study_id>Rizzoli HA-MEN</org_study_id>
    <nct_id>NCT02629380</nct_id>
  </id_info>
  <brief_title>Early Viscosupplementation After Partial Meniscectomy: a Randomized Controlled Trial</brief_title>
  <acronym>HA-MEN</acronym>
  <official_title>Early Viscosupplementation After Partial Meniscectomy: a Double Blind, Placebo Controlled Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto Ortopedico Rizzoli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto Ortopedico Rizzoli</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The rational of intra-articular viscosupplementation is based on both the biological and
      mechanical properties of HA, which exerts positive effects on the modulation of the entire
      joint environment.

      The aim of the present double blind controlled study was to evaluate the effects in terms of
      pain control and functional recovery provided by a single intra-operative injection of HA
      performed at the end of arthroscopic partial meniscectomy.

      Patients included in this trial were randomized in two treatment groups: the first one
      received a single injection of HA (Hymovis 24 mg/3ml, Fidia Farmaceutici Spa, Padova, Italy)
      at the end of the arthroscopic meniscectomy, whereas the second group was treated by surgery
      alone.

      All patients were evaluated basally, at 15, 30, 60, and 180 days after surgery by the
      following evaluation tools: IKDC (International Knee Documentation Committee) subjective, VAS
      (Visual Analogue Score) for pain, EQ-VAS for general Health Status, KOOS (Knee Injury and
      Osteoarthritis Outcome Score) and Tegner score. Furthermore, during the basal evaluation and
      at each follow-up visit up to 2 months, active and passive Range of Motion (ROM) of both the
      operated and contralateral knee were documented; also in addition, the trans-patellar
      circumference of both knees was registered to assess the trend of knee swelling over time.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in IKDC (International Knee Documentation Committee) score</measure>
    <time_frame>basal, 15,30,60,180 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in KOOS (Knee Injury and Osteoarthritis Outcome Score)</measure>
    <time_frame>basal, 15,30,60,180 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Tegner Score</measure>
    <time_frame>basal, 15,30,60,180 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in VAS (Visual Analogue Scale) for pain</measure>
    <time_frame>basal, 15,30,60,180 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in EQ-VAS for general health</measure>
    <time_frame>basal, 15,30,60,180 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in transpatellar circumference over time</measure>
    <time_frame>basal, 15,30,60,180 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in active and passive ROM</measure>
    <time_frame>basal, 15,30,60,180 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events report</measure>
    <time_frame>15 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events report</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events report</measure>
    <time_frame>60 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Meniscus Lesion</condition>
  <arm_group>
    <arm_group_label>Hyaluronic acid group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single injection of 3 ml HA (Hymovis, Fidia Farmaceutici SpA, Padova, Italy) at the end of the arthroscopic meniscectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>meniscectomy alone</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Arthroscopic meniscectomy alone</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>hyaluronic acid</intervention_name>
    <description>A single injection of 3 ml hyaluronic acid to be performed under arthroscopic view at the end of meniscectomy</description>
    <arm_group_label>Hyaluronic acid group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>meniscectomy alone</intervention_name>
    <description>The patients randomized in this group will receive arthroscopic meniscectomy alone</description>
    <arm_group_label>meniscectomy alone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. chronic symptomatic meniscal tears requiring partial resection;

          2. healthy contra-lateral knee (i.e. no pain or functional limitation in the
             contra-lateral joint);

        Exclusion Criteria:

          1. previous surgery on the index knee;

          2. other concurrent articular lesion requiring surgical treatment (e.g.: cartilage or
             ligament injuries);

          3. history of knee infectious arthritis;

          4. concurrent rheumatic, metabolic or severe systemic disease;

          5. Body Mass Index (BMI) &gt; 30;

          6. known hypersensibility or allergy to/towards HA ;

          7. alcohol or other substances abuse/excess.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elizaveta Kon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>II Clinic and Nano-biotechnology Lab, Rizzoli Orthopedic Institute, Bologna, Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>II Orthopaedic Clinic, Rizzoli Orthopaedic Institute</name>
      <address>
        <city>Bologna</city>
        <state>Emilia Romagna</state>
        <zip>40136</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Edouard P, Rannou F, Coudeyre E. Animal evidence for hyaluronic acid efficacy in knee trauma injuries. Review of animal-model studies. Phys Ther Sport. 2013 May;14(2):116-23. doi: 10.1016/j.ptsp.2013.02.001. Epub 2013 Mar 16. Review.</citation>
    <PMID>23506791</PMID>
  </reference>
  <reference>
    <citation>Freymann U, Endres M, Goldmann U, Sittinger M, Kaps C. Toward scaffold-based meniscus repair: effect of human serum, hyaluronic acid and TGF-ÃŸ3 on cell recruitment and re-differentiation. Osteoarthritis Cartilage. 2013 May;21(5):773-81. doi: 10.1016/j.joca.2013.02.655. Epub 2013 Mar 5.</citation>
    <PMID>23473977</PMID>
  </reference>
  <reference>
    <citation>Thein R, Haviv B, Kidron A, Bronak S. Intra-articular injection of hyaluronic acid following arthroscopic partial meniscectomy of the knee. Orthopedics. 2010 Oct 11;33(10):724. doi: 10.3928/01477447-20100826-11.</citation>
    <PMID>20954664</PMID>
  </reference>
  <reference>
    <citation>Tan GK, Dinnes DL, Butler LN, Cooper-White JJ. Interactions between meniscal cells and a self assembled biomimetic surface composed of hyaluronic acid, chitosan and meniscal extracellular matrix molecules. Biomaterials. 2010 Aug;31(23):6104-18. doi: 10.1016/j.biomaterials.2010.04.018. Epub 2010 May 14.</citation>
    <PMID>20471080</PMID>
  </reference>
  <reference>
    <citation>Westrich G, Schaefer S, Walcott-Sapp S, Lyman S. Randomized prospective evaluation of adjuvant hyaluronic acid therapy administered after knee arthroscopy. Am J Orthop (Belle Mead NJ). 2009 Dec;38(12):612-6.</citation>
    <PMID>20145786</PMID>
  </reference>
  <reference>
    <citation>Waddell DD, Bert JM. The use of hyaluronan after arthroscopic surgery of the knee. Arthroscopy. 2010 Jan;26(1):105-11. doi: 10.1016/j.arthro.2009.05.009. Epub 2009 Nov 25. Review.</citation>
    <PMID>20117634</PMID>
  </reference>
  <reference>
    <citation>Cake M, Read R, Edwards S, Smith MM, Burkhardt D, Little C, Ghosh P. Changes in gait after bilateral meniscectomy in sheep: effect of two hyaluronan preparations. J Orthop Sci. 2008 Nov;13(6):514-23. doi: 10.1007/s00776-008-1279-6. Epub 2008 Dec 17.</citation>
    <PMID>19089539</PMID>
  </reference>
  <reference>
    <citation>Mathies B. Effects of Viscoseal, a synovial fluid substitute, on recovery after arthroscopic partial meniscectomy and joint lavage. Knee Surg Sports Traumatol Arthrosc. 2006 Jan;14(1):32-9. Epub 2005 May 26.</citation>
    <PMID>15918064</PMID>
  </reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 10, 2015</study_first_submitted>
  <study_first_submitted_qc>December 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 14, 2015</study_first_posted>
  <last_update_submitted>September 12, 2017</last_update_submitted>
  <last_update_submitted_qc>September 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istituto Ortopedico Rizzoli</investigator_affiliation>
    <investigator_full_name>Federica Balboni</investigator_full_name>
    <investigator_title>BScD</investigator_title>
  </responsible_party>
  <keyword>meniscectomy</keyword>
  <keyword>hyaluronic acid</keyword>
  <keyword>intra-op injection</keyword>
  <keyword>randomized controlled trial</keyword>
  <keyword>placebo</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

